glp-1/gcgr dual agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research The dual GLP-1/glucagon receptor agonist

doi: 10.1185/030079905x75078

Questions for Cramer

How to decide which medication is right for you The choice between Qsymia and a GLP-1 medication is not one you should make alone

Even though clinical trials have shown some positive results on motor function in patients with Parkinson's disease treated with exenatide (73), a recent Cochrane review found 'low-certainty evidence that exenatide improves motor impairment' in patients with Parkinsons disease (74)

If considering weight loss medication, it helps to understand the factors influencing your weight

For others, the fees and communication gaps make it harder to trust the process